Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is poised for a strong second half of 2026 and fiscal year 2027, with "green shoots" already emerging for its MAGiC catheter and a growing demand for its robotic systems. Despite missing Q1 revenue estimates and facing headwinds in its disposable business, the company's efforts to ramp production of the catheter and expand its installed base bode well for future growth. As a result, the optimistic outlook for Stereotaxis's recurring revenues and growing pipeline of system sales make it a bullish investment opportunity.

Bears say

Stereotaxis is facing challenges in meeting its revenue projections due to delays in system sales and the slow adoption of new technologies by healthcare providers. There are also potential risks related to collaboration with other manufacturers and suppliers, installation and regulatory issues, and competition in the market. Despite its promising technology, the company's financial performance may be negatively impacted by these factors.

Stereotaxis Inc (STXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 4 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.